Marwaan Rylands
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marwaan Rylands has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Clinton Gareth Lancaster Veale
Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7701, South Africa
2 shared publications - Adrienne Lesley Edkins
The Biomedical Biotechnology Research Unit (BioBRU), Department of Biochemistry and Microbiology, Rhodes University, Makhanda, 6139, South Africa
1 shared publication - Beatriz G. de la Torre
University of KwaZulu-Natal
1 shared publication - Conrad Veranso Simoben
Structural Genomics Consortium University of Toronto Toronto Ontario Canada
1 shared publication - Daniel A. Kusza
Institute of Organic Chemistry, Technische Universität Braunschweig, Hagenring 30, 38106 Braunschweig, Germany
1 shared publication - David James Clarke
EaStCHEM School of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh EH93FJ, UK
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (6) , 1099-1107
Native MS and ligand observed NMR uncovers subtle SLiM binding variations that mediate HSP90-Hop PPI modulation
Orthogonal native mass spectrometry and ligand observed NMR elucidated subtle variations of SLiM binding TRP2A and provided a structural rationalization for HSP90-Hop PPI inhibition, and for future peptidomimetic optimisation.
- 6 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (6) , 1099-1107
Open AccessNative MS and ligand observed NMR uncovers subtle SLiM binding variations that mediate HSP90-Hop PPI modulation
Orthogonal native mass spectrometry and ligand observed NMR elucidated subtle variations of SLiM binding TRP2A and provided a structural rationalization for HSP90-Hop PPI inhibition, and for future peptidomimetic optimisation.
- Open Access
- 7 April 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (5) , 2569-2574
Adapting Bloom’s Taxonomy to Trace the Evolution of Assessment Patterns in Honors Organic Chemistry
- 7 April 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (5) , 2569-2574
Open AccessAdapting Bloom’s Taxonomy to Trace the Evolution of Assessment Patterns in Honors Organic Chemistry
- 24 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01035
Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies
A previously undescribed iboga‐indole alkaloid, voacamine A ( 1 ), and the known alkaloids, voacamine ( 2 ), voacorine ( 3 ), and voacangine ( 4 ) were isolated from the stem bark of Voacanga africana . The structures of the alkaloids were established by one‐ and two‐dimensional nuclear magnetic resonance analyses as well as by comparison with published data. The antiplasmodial activity of the alkaloids was assessed on a chloroquine‐sensitive 3D7 Plasmodium falciparum ( Pf3D7 ) strain, and the half‐maximal inhibitory concentration (IC 50 ) values were determined. Alkaloids 2 and 3 showed good in vitro antiplasmodial activity with IC 50 values of 5.734 ± 1.365 and 5.319 ± 2.206 µg/mL, respectively, at the concentration tested. A plausible biogenetic pathway of the bisindole alkaloids has been proposed. Protein‐ligand co‐folding was used to generate protein‐ligand complexes for the pfATP6 protein target and the isolated alkaloids. The stability of the modelled complexes was evaluated using molecular dynamics simulation. Scoring metrics of the generated complexes coupled to molecular mechanics generalized‐born solvation rescoring of the modelled ligand poses were employed to explain the antimalarial structure‐activity relationship for the investigated compounds. Alkaloids 2 and 3 can be considered as possible scaffolds for designing new antiplasmodial lead compounds.
- 24 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01035
Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies
A previously undescribed iboga‐indole alkaloid, voacamine A ( 1 ), and the known alkaloids, voacamine ( 2 ), voacorine ( 3 ), and voacangine ( 4 ) were isolated from the stem bark of Voacanga africana . The structures of the alkaloids were established by one‐ and two‐dimensional nuclear magnetic resonance analyses as well as by comparison with published data. The antiplasmodial activity of the alkaloids was assessed on a chloroquine‐sensitive 3D7 Plasmodium falciparum ( Pf3D7 ) strain, and the half‐maximal inhibitory concentration (IC 50 ) values were determined. Alkaloids 2 and 3 showed good in vitro antiplasmodial activity with IC 50 values of 5.734 ± 1.365 and 5.319 ± 2.206 µg/mL, respectively, at the concentration tested. A plausible biogenetic pathway of the bisindole alkaloids has been proposed. Protein‐ligand co‐folding was used to generate protein‐ligand complexes for the pfATP6 protein target and the isolated alkaloids. The stability of the modelled complexes was evaluated using molecular dynamics simulation. Scoring metrics of the generated complexes coupled to molecular mechanics generalized‐born solvation rescoring of the modelled ligand poses were employed to explain the antimalarial structure‐activity relationship for the investigated compounds. Alkaloids 2 and 3 can be considered as possible scaffolds for designing new antiplasmodial lead compounds.